Regular ArticlePotential Cholestatic Activity of Various Therapeutic Agents Assessed by Bile Canalicular Membrane Vesicles Isolated from Rats and Humans
References (37)
- et al.
Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver
Gastroenterology
(2000) - et al.
ATP-dependent efflux of 2,4-dinitrophenyl-S-glutathione
J. Biol. Chem.
(1995) - et al.
The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: Probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites
Drug Metab. Pharmacokin.
(2002) - et al.
A proposed mechanism for chlorpromazine jaundice-defective hepatic sulphoxidation combined with rapid hydroxylation
J. Hepatol.
(1988) - et al.
Role of bile salts in colchicine-induced hepatotoxicity. Implication for hepatocellular integrity and function
Toxicology
(1997) - et al.
Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver
Gastroenterology
(1994) - et al.
Molecular pathogenesis of cholestasis
New Engl. J. Med.
(1998) - et al.
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
Nat. Genet.
(1998) - et al.
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome
Hepatology
(1997) - et al.
Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane
FEBS lett.
(1994)
Primary active transport of organic anions on bile canalicular membrane in humans
Am. J. Physiol.
(1999)
A pharmacokinetic analysis program (MULTI) for microcomputer
J. Pharmacobio.-Dyn.
(1981)
Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport
Annu Rev Pharmacol Toxicol.
(1998)
Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments
Drug Metab Dispos.
(2000)
Prediction of pharmacokinetic alterations caused by drug-drug interactions: Metabolic interaction in the liver
Pharmacol. Rev.
(1998)
Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man
Dig. Dis. Sci.
(1992)
Colchicine toxicity
Australasian annals of Medicine.
(1969)
Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: In vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat
Mol. Pharmacol.
(2000)
Cited by (0)
Copyright © 2003 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.